There is no doubt that the detection and analysis of CTC markers (EpCAM and CK8, 18, CD45 Vimentin, Twist and 19) and CSCs markers (Nanog) are useful for evaluating tumor progression, developing tumor drugs, and monitoring the disease process of cancer patients. This evidence concerns the gene TWIST1 and cancer.